Literature DB >> 16155192

Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2.

A Saxena1, D de Lagarde, H Leonard, S L Williamson, V Vasudevan, J Christodoulou, E Thompson, P MacLeod, D Ravine.   

Abstract

BACKGROUND: Rett syndrome (RTT) is an X linked neuro-developmental disorder affecting mostly girls. Mutations in the coding region of MECP2 are found in 80% of classic RTT patients. Until recently, the region encoding MECP2 was believed to comprise exons 2, 3, and 4 with the ATG start site located at the end of exon 2 (MeCP2_e2).
METHODS: Recent reports of another mRNA transcript transcribed from exon 1 (MeCP2_e1) prompted us to screen exon 1 among RNA samples from 20 females with classic or atypical RTT.
RESULTS: A previously reported 11 base pair deletion in exon 1 was detected in one subject with a milder phenotype. Although RNA expression for both protein isoforms was detected from the mutant allele, evaluation of MeCP2 protein in uncultured patient lymphocytes by immunocytochemistry revealed that MeCP2 protein production was restricted to only 74-76% of lymphocytes. X chromosome inactivation studies of genomic DNA revealed similar XCI ratios at the HUMARA locus (73:27 with HpaII and 74:26 with McrBC). We have demonstrated that translation but not transcription of the MeCP2_e2 isoform is ablated by the 11 nucleotide deletion, 103 nucleotides upstream of the e2 translation start site.
CONCLUSIONS: These findings reveal that nucleotides within the deleted sequence in the 5'-UTR of the MeCP2_e2 transcript, while not required for transcription, are essential for translation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155192      PMCID: PMC2593027          DOI: 10.1136/jmg.2005.036244

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  32 in total

Review 1.  Control of eukaryotic protein synthesis by upstream open reading frames in the 5'-untranslated region of an mRNA.

Authors:  Hedda A Meijer; Adri A M Thomas
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

Review 2.  Clinical manifestations and stages of Rett syndrome.

Authors:  Bengt Hagberg
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

3.  Exploring the repertoire of RNA secondary motifs using graph theory; implications for RNA design.

Authors:  Hin Hark Gan; Samuela Pasquali; Tamar Schlick
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

4.  Describing the phenotype in Rett syndrome using a population database.

Authors:  L Colvin; S Fyfe; S Leonard; T Schiavello; C Ellaway; N De Klerk; J Christodoulou; M Msall; H Leonard
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

5.  InterRett--The application of bioinformatics to International Rett syndrome research.

Authors:  H Moore; H Leonard; S Fyfe; N De Klerk; N Leonard
Journal:  Ann Hum Biol       Date:  2005 Mar-Apr       Impact factor: 1.533

6.  Analysis of the distribution of CAG repeats and X-chromosome inactivation status of HUMARA gene in healthy female subjects using improved fluorescence-based assay.

Authors:  M Karasawa; N Tsukamoto; A Yamane; K Okamoto; T Maehara; A Yokohama; Y Nojima; M Omine
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

7.  Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations?

Authors:  H Leonard; L Colvin; J Christodoulou; T Schiavello; S Williamson; M Davis; D Ravine; S Fyfe; N de Klerk; T Matsuishi; I Kondo; A Clarke; S Hackwell; Y Yamashita
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

8.  InterRett and RettBASE: International Rett Syndrome Association databases for Rett syndrome.

Authors:  Susan Fyfe; Angela Cream; Nick de Klerk; John Christodoulou; Helen Leonard
Journal:  J Child Neurol       Date:  2003-10       Impact factor: 1.987

Review 9.  Regulation of mRNA translation by 5'- and 3'-UTR-binding factors.

Authors:  Gavin S Wilkie; Kirsten S Dickson; Nicola K Gray
Journal:  Trends Biochem Sci       Date:  2003-04       Impact factor: 13.807

Review 10.  Rett syndrome: the complex nature of a monogenic disease.

Authors:  Alessandra Renieri; Ilaria Meloni; Ilaria Longo; Francesca Ariani; Francesca Mari; Chiara Pescucci; Franca Cambi
Journal:  J Mol Med (Berl)       Date:  2003-05-16       Impact factor: 4.599

View more
  15 in total

Review 1.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

Review 2.  The molecular pathology of Rett syndrome: synopsis and update.

Authors:  Schahram Akbarian; Yan Jiang; Genevieve Laforet
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.

Authors:  Mei-Rong Li; Hong Pan; Xin-Hua Bao; Yu-Zhi Zhang; Xi-Ru Wu
Journal:  J Hum Genet       Date:  2006-11-07       Impact factor: 3.172

Review 4.  Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).

Authors:  Tina KhorshidAhmad; Crystal Acosta; Claudia Cortes; Ted M Lakowski; Surendiran Gangadaran; Michael Namaka
Journal:  Mol Neurobiol       Date:  2015-01-13       Impact factor: 5.590

5.  The first missense mutation causing Rett syndrome specifically affecting the MeCP2_e1 isoform.

Authors:  Yann Fichou; Juliette Nectoux; Nadia Bahi-Buisson; Haydeé Rosas-Vargas; Benoit Girard; Jamel Chelly; Thierry Bienvenu
Journal:  Neurogenetics       Date:  2008-11-26       Impact factor: 2.660

6.  Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.

Authors:  Rosemary E Teresi; Kevin M Zbuk; Marcus G Pezzolesi; Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2007-08-15       Impact factor: 11.025

7.  CAGE-defined promoter regions of the genes implicated in Rett Syndrome.

Authors:  Morana Vitezic; Nicolas Bertin; Robin Andersson; Leonard Lipovich; Hideya Kawaji; Timo Lassmann; Albin Sandelin; Peter Heutink; Dan Goldowitz; Thomas Ha; Peter Zhang; Annarita Patrizi; Michela Fagiolini; Alistair R R Forrest; Piero Carninci; Alka Saxena
Journal:  BMC Genomics       Date:  2014-12-24       Impact factor: 3.969

8.  Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes.

Authors:  Robby M Zachariah; Carl O Olson; Chinelo Ezeonwuka; Mojgan Rastegar
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

Review 9.  MECP2 genomic structure and function: insights from ENCODE.

Authors:  Jasmine Singh; Alka Saxena; John Christodoulou; David Ravine
Journal:  Nucleic Acids Res       Date:  2008-09-27       Impact factor: 16.971

Review 10.  The Utility of Next-Generation Sequencing in Gene Discovery for Mutation-Negative Patients with Rett Syndrome.

Authors:  Wendy Anne Gold; John Christodoulou
Journal:  Front Cell Neurosci       Date:  2015-07-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.